Samarium 153 Lexidronam
What is Samarium 153 Lexidronam Samarium-153 lexidronam is a parenteral radioisotope indicated for the relief of pain associated with metastatic bone cancer. The onset of analgesic effect is usually within 7 days, with maximum pain relief generally occurring 3 to 4 weeks after administration. It consists of a stable complex of radioactive samarium and a …